Keywords

andexanet alfa, avatrombopag maleate, coagulation factor Xa (recombinant) inactivated-zhzo, eravacycline dihydrochloride, fostamatinib disodium hexahydrate, inotersen sodium, lusutrombopag, moxidectin, patisiran, plazomicin

Authors

1. Hussar, Daniel A. PhD

Abstract

Abstract: This article reviews nine drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.